The Oncology Podcast, brought to you by oncologynews.com.au, is proud to present the latest episode in our ‘The OJC Meets…’ series in which Professor Eva Segelov chats with Dr Mark Lewis, oncologist and Director of Gastrointestinal Oncology at Intermountain Healthcare, Salt Lake City, USA.
Mark is a medical oncologist, physician-patient and avid Twitter user, who has multiple neuroendocrine neoplasia type 1. He underwent a Whipple surgical procedure for his pancreatic neuroendocrine tumour in 2017, which he live tweeted.
He shares insights into practicing as an oncologist whilst also being a patient and chats about the challenges of navigating a genetic tumour syndrome which has affected him, his father and his son.
The day it stops being emotional is the day I want to stop doing it because if I become insensate to the human side of this, then I just become a kind of chemo-dispensing robot and that’s exactly what I don’t want to be…
It’s an honest, insightful and uplifting episode so we hope you enjoy. Please tweet feedback and comments to us (@OncologyNewsAus), Eva (@profevasegelov) and Mark (@marklewisMD).
This Week’s Team:
Professor Eva Segelov
Eva Segelov
Professor Eva Segelov is a Medical Oncologist and is Director of Oncology at Monash University and Monash Health, Melbourne, Victoria, previously Senior Medical Oncologist at St Vincent’s Hospital, St Vincent’s Private Hospital and St Vincent’s Clinic and Associate Professor of Medicine, University of New South Wales.
Eva has an interest in academic clinical trials in GI and breast cancer and has been a member of the AGITG since 2003. She has clinical trials expertise, links with national and international trials groups, and extensive experience with adult medical education.
Mark Lewis
Mark Lewis
Dr. Mark A. Lewis received his medical degree, completed his internal medicine residency, and served as chief resident at Baylor College of Medicine in Houston, Texas, USA. After completing a hematology/oncology fellowship at the Mayo Clinic in Rochester, Minnesota, where he served as chief fellow, he returned to Houston to work at the MD Anderson Cancer Center for four years, with a dual appointment in general & gastrointestinal medical oncology, before assuming the directorship of gastrointestinal oncology at Intermountain Healthcare in 2016. He is also the co-chair of adolescent & young adult (AYA) oncology in the SWOG cooperative group, currently serving a five-year term in that position.
Rachael Babin
Rachael Babin
Rachael Babin is Editor-in-Chief of The Oncology Newsletter and Publisher of www.oncologynews.com.au. For regular oncology updates for healthcare professionals, please subscribe to The Oncology Newsletter.
With thanks to Eva Segelov, Mark Lewis and Graham Knowles.
